The report "Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region - Global Forecast to 2028", size is projected to grow from USD 33.0 billion in 2023 and reach USD 43.3 billion by 2028, at a CAGR of 5.6% from 2023 to 2028. The expansion of this market can be credited to several factors, including the upward trend in the elderly population, the surge in worldwide healthcare spending, the advancement of implantable devices, and consumers transitioning from conventional to more sophisticated wound care solutions.
Browse 377 market data Tables and 51 Figures spread through 307 Pages and in-depth TOC on "Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-foam-market-176803616.html
The flexible segment to lead the medical foam market during 2023-2028
Flexible foam stands out as the most extensively utilized due to its softness, flexibility, and durability. The rise in demand for this foam type is linked to its more economical nature compared to rigid and spray foam options. Moreover, its considerable use in bedding and cushioning, packaging medical devices, and wound care dressing has significantly propelled market expansion. The prevalence of flexible foam in these applications is due to its attributes, including softness, moisture resistance, and superior impact and mechanical properties.
The polymer segment will lead the medical foam market during the forecast period.
In terms of material, the polymer segment is anticipated to hold the leading position in the medical foam industry. This segment's growth is credited to its widespread availability, ease of production, and cost-effectiveness. Polymer foams exhibit characteristics such as lightweight structure, heat retention, sound absorption, biocompatibility, and exceptional cushioning. Key polymer foam varieties utilized in medical contexts encompass polyurethane foam, polystyrene foam, polyolefin foam, among others.
Medical packaging is expected to register the highest growth during the forecast period.
In the forecast period, the most significant surge in the global medical foam market is projected to occur within medical packaging segment. Safeguarding the integrity and hygiene of medical products is paramount, making the packaging of medical devices, tools, and equipment very crucial. This encompasses the packaging of implants, medical tools, equipment, and in-vitro diagnostic devices (IVDs). The selection of packaging material varies according to the application and relies on the product's intended function. For instance, plastics or metals find use in implant packaging.
Asia Pacific will lead the global medical foam market during the forecast period.
In 2022, the Asia Pacific region held the dominant share in the global medical foam industry. Forecasts suggest that this region will experience the highest Compound Annual Growth Rate (CAGR) between 2023 and 2028. The Asia Pacific market for medical foam is emerging as a lucrative sector due to demographic shifts, rising healthcare expenditure, industrial advancements, and improving economic circumstances. With approximately 60% of the world's population residing in this region, there is extensive utilization of medical packaging, prosthetics, and medical devices.
Key Players
Some of the leading manufacturers of medical foam profiled in this report are The Dow Chemical Company (US), Sekisui Chemical Co., Ltd. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International SA (Germany), Rogers Corporation (US), Freudenberg Group (Germany), and Molnlycke Health Care (Sweden).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]